C-Type natriureticpeptide-38 (Triakis scyllium reduced) (9CI)(145017-32-9)
- Name: C-Type natriureticpeptide-38 (Triakis scyllium reduced) (9CI)
- Synonyms:C-Typenatriuretic factor-38 (Triakis scyllium reduced); C-Type natriuretic factor-38(Scyliorhinus canicula reduced); C-Type natriuretic peptide-38 (Scyliorhinuscanicula reduced); C-Type natriuretic peptide-38 (shark); L-Cysteine,L-lysyl-L-a-aspartyl-L-leucyl-L-seryl-L-asparaginyl-L-asparaginyl-L-prolyl-L-leucyl-L-arginyl-L-phenylalanyl-L-arginylglycyl-L-arginyl-L-seryl-L-lysyl-L-lysylglycyl-L-prolyl-L-seryl-L-arginylglycyl-L-cysteinyl-L-phenylalanylglycyl-L-valyl-L-lysyl-L-leucyl-L-a-aspartyl-L-arginyl-L-isoleucylglycyl-L-alanyl-L-methionyl-L-serylglycyl-L-leucylglycyl-
- Molecular Formula:C173H293 N59 O49 S2
- Molecular Weight:
- CAS Registry Number:145017-32-9
- EINECS:
- Melting Point:
- Water Solubility:

Other Product
- 92062-14-1/Solvent naphtha (petroleum), heavy
- 50767-24-3/3-[3-hydroxy-4-(hydroxymethyl)cyclopentyl]-2,3-dihydro-7H-[1,2,3]triazolo[4,5-d]pyrimidin-7-one
- 56207-43-3/2,2,6-trichloro-7-oxabicyclo[4.1.0]heptane-1-carbonitrile
- 61788-86-1/Fatty acids, coco, 2-(2-hydroxyethoxy)ethyl esters
- 5444-62-2/8-chloro-2-methyl-N,N-dipropyl-5H-purin-6-amine
- 93195-40-5/Cholecystokinin-39 (rat)
- 73826-49-0/1-{3-methyl-4-[(3-methylbutyl)sulfanyl]phenyl}-3-piperidin-1-ylpropan-1-one hydrochloride
- 7548-11-0/2H-2,7a-Methanoindolo[2,3-a]quinolizine-13,- 13-dimethanol,3-ethylidene-1,3,4,6,7,12,12a,- 12b-octahydro-,(2S,3E,7aS,12aS,12bS)-
- 93918-69-5/cerium(3+) bromate
- 78370-11-3/Benzeneacetonitrile,R-[3-[[2-(3,4-dimethoxyphenyl) ethyl]methylamino]propyl]-4-fluoro-R- (1-methylethyl)-
- 65997-19-5/STAINLESS STEEL
- 41428-67-5/4-hydroxy-2-oxo-1,3,2-dioxaphosphetan-2-ium
- 27058-74-8/PGLU-HIS-GLY AMIDE
- 4902-24-3/5-tert-butyl 1-methyl N-[(benzyloxy)carbonyl]valylglutamate
- 140413-34-9/6,9-dimethyl-5-oxo-5,6-dihydropyrido[2,3-b][1,5]benzoxazepine-7-carboxylic acid
- 91001-98-8/Fatty acids, castor-oil, maleates, sulfonated, trisodium salts
- 95101-13-6/Norleucine, 2-butyl-N-phenyl-, 2-(4-chlorophenyl)hydrazide
- 27236-80-2/10-UNDECENOYL CHLORIDE
- 115995-13-6/tomencephalin
- 145017-32-9/C-Type natriureticpeptide-38 (Triakis scyllium reduced) (9CI)
- 18100-68-0/2H-1,4-Benzodiazepin-2-one,5-(2-chlorophenyl)- 1,3-dihydro-1-methyl-
- 68424-36-2/(C9-C15)Neoalkanoate acid, manganese salt
- 61683-86-1/4-Isopropyl-2-(4-methoxyphenyl)-5,5-dimethyl-1,3-dioxane
- 6625-08-7/2-HYDROXY-3-METHYL-4-QUINOLINECARBOXYLIC ACID
- 157998-95-3/1-Propanone,2,3-dihydroxy-1-[(1R,2R,4aS,6S,8aR)-1,2,4a,5,6,7,8,8a-octahydro-1,2,6-trimethyl-1-naphthalenyl]-,rel-
- 94247-05-9/isotridecyl methacrylate
- 5842-85-3/(4E)-4-(2,5-dimethoxybenzylidene)-2-[(E)-2-phenylethenyl]-1,3-oxazol-5(4H)-one
- 96873-90-4/Tar acids, cresylic, residues, polymers with Bu alc, formaldehyde and phenol
- 68918-59-2/Soybean oil, polymer with glycerol, maleic anhydride, phthalic anhydride and tall oil
- 79951-58-9/3,5,12-trihydroxy-3-(1-hydroxyethyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 2,3,6-trideoxy-3-morpholin-4-yl-alpha-L-lyxo-hexopyranoside hydrochloride (1:1)